X-ray

In Print

Premium

Microarray-Related Papers of Note Published in March 2009

The deal calls for Proteros to use its crystallography platform to decipher the X-ray structure of Axikin's protein, develop assays, identify active fragments, and develop the selected fragments into novel lead drug candidates.

Though the firm's revenues were down year over year for the quarter, its full-year 2008 revenues increased 7 percent. Investors also sent Bruker's shares up in early trade, as the firm handily beat analysts' consensus estimate for EPS.

Industry Briefs

Premium

Mosaiques, Bruker, Kinaxo, Xencor, CSL, Hybrigenics, Adlyfe, Wyeth

Receipts for the firm’s life sciences division, which houses its LC-MS tools, slid 1 percent but company officials said that LC-MS and mass-spec sales experienced double-digit growth.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.